Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck Gets First FDA Approval of Keytruda
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM).
Keytruda Plus Chemotherapy Approved for Malignant Pleural Mesothelioma
The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.
Merck Gets First FDA Approval of Keytruda in Malignant Pleural Mesothelioma
Merck & Co. has won its first U.S. approval for use of its blockbuster cancer drug Keytruda in patients with malignant pleural mesothelioma, a rare cancer that grows in the membrane that lines the walls of the chest and lungs.
USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination
FDA Approves Keytruda Plus Chemo for Pleural Mesothelioma Subset
Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on findings from the KEYNOTE-483 trial.
Pembrolizumab Approved With Chemotherapy for Malignant Pleural Mesothelioma
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM) in combination with pemetrexed and platinum chemotherapy.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Pleural
mesothelioma
is a type of cancer which develops in the tissue that lines the lungs or pleura. This is the first time
Keytruda
has been approved for the given indication in the United States.
Merck: KEYTRUDA Plus Chemotherapy Gets FDA Approval For Malignant Pleural Mesothelioma In Adults
Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug
Keytruda
as a treatment for malignant plural
mesothelioma
, a rare cancer associated ...
Monthly Prescribing Reference
7d
Keytruda Plus Chemotherapy Approved for Malignant Pleural Mesothelioma
The Food and Drug Administration (FDA) has approved
Keytruda
® (pembrolizumab ... unresectable advanced or metastatic malignant pleural
mesothelioma
(MPM). The approval was supported by data ...
5h
Merck fails in late-stage trial for Keytruda combo in colon cancer
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Penn suspends law professor
Campaign office damaged
Study: Myopia on the rise
To cut Atlanta service, jobs
Woman dies in 'suicide pod’
School book bans surge
CA new gun control laws
New home sales fall
Storm Helene strengthens
$375M military aid to UKR
Chemical leak in OH county
NYC schools boss retiring
Union gets more voting time
Pac-12 sues Mountain West
Israel intercepts first missile
US to waive visas for Qatar
Briefed on Iranian threats
Calls strike against 'LoL’
Texas AG appeal denied
ISR: Hezbollah leader killed
Johnny Cash statue unveiled
InfoWars to be auctioned off
China conducts ICBM test
Executed by lethal injection
X account hacked
Rioter mistakenly released
‘Trump Train’ jury verdict
Time for COVID, flu shots
Feedback